Acomplia diet pill is finally approved for sale in the UK. Developed by Sanofi, diet pill Acomplia (rimonabant) was highly anticipated pill for weight loss which was formally launched on June 28th in Britain. Now the diet drug can be purchased by patients who obtain a prescription from a general practitioner.

Rimonabant is not only beneficial for obese people but it is also prescribed to those who wish to quit smoking. Although primarily it is for obese people, still it’s usefulness for the smoking cessation also.

Although acomplia benefits more of the obese people, still it’s usefulness for the community of smokers cannot be left unnoticed. Its trial has confirmed that it is an effective way to relinquish smoking. Though acomplia is one of the most promising weight loss drugs, it should still not be taken without the consultation of a doctor. No one can better advise you on the drug than your physician. He may not allow you to take acomplia if you have had some serious health problems in the past.

What were the results of Acomplia Clinical trial studies?

• In clinical studies, Acomplia has been shown to improve a wide array of cardiometabolic risk factors as well as promoting sustained weight loss4,5.
• Approximately half of the observed improvement in HDL-cholesterol, triglycerides and HbA1C (an indicator of blood sugar control) in patients who received Acomplia 20mg was beyond that expected from weight loss alone.